odiparcil has been researched along with warfarin in 1 studies
| Studies (odiparcil) | Trials (odiparcil) | Recent Studies (post-2010) (odiparcil) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
|---|---|---|---|---|---|
| 13 | 2 | 10 | 36,573 | 2,143 | 14,728 |
| Protein | Taxonomy | odiparcil (IC50) | warfarin (IC50) |
|---|---|---|---|
| Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abboud, MA; Burns-Kurtis, CL; Danoff, TM; Erhardt, JA; Koster, PF; Pillarisetti, K; Toomey, JR; Valocik, RE | 1 |
1 other study(ies) available for odiparcil and warfarin
| Article | Year |
|---|---|
A comparison of the beta-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosis.
Topics: Animals; Anticoagulants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glycosaminoglycans; Glycosides; Hemorrhage; Heparin Cofactor II; Protamines; Rats; Vena Cava, Inferior; Venous Thrombosis; Warfarin | 2006 |